Aptiv Solutions Acquires SRA Global Clinical Development


Company News Release

Aptiv Solution announced it has acquired SRA Global Clinical Development (GCD), the CRO division of SRA International, Inc. based in Durham, N.C., with offices in Paris, France and Milton Park, England.

SRA GCD and its predecessor companies have built a substantial business by delivering high-quality clinical trial and regulatory services around the globe. SRA GCD’s regulatory consulting team based near London adds significantly to the Aptiv Solutions regulatory services group. The additional talent from SRA GCD accelerates Aptiv Solutions leadership in regulatory services.

“We believe the GCD business, as a part of Aptiv Solutions, has greater opportunity to pursue a wider range of initiatives that align with its mission,” said SRA President and CEO Bill Ballhaus

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.